Status:
COMPLETED
Analgesic Efficacy of Intravenous Dexmedetomidine for Supraclavicular Plexus Block
Lead Sponsor:
Hôpital du Valais
Conditions:
Surgery
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
The goal of the study is to compare the duration of analgesia in patients undergoing forearm or hand surgery with a supraclavicular brachial plexus block, who receive either iv dexmedetomidine or plac...
Detailed Description
Most surgical interventions on the forearm and the hand in Valais Hospital are performed under regional anesthesia. This ensures intraoperative patient comfort and reduces pain during the first 6 to 1...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients undergoing elbow, forearm or hand surgery under supraclavicular brachial plexus block Patients who are ASA physical status I-III
- Exclusion criteria
- Patient refusal
- ASA physical status IV
- History of hypersensitivity or intolerance to dexmedetomidine
- History of hypersensitivity or intolerance to dexamethasone
- History of hypersensitivity or intolerance to local anesthetics
- History of recent (\< 1 year) cerebrovascular insult
- Second or third degree heart block
- Uncontrolled hypotension
- Conditions contraindicating supraclavicular brachial plexus block: neurological deficit or neuropathy of the arm, severe hepatic dysfunction (Child B and C), coagulopathy, malignancy or infection in the area above the clavicle
- Chronic opioid use
- Pregnancy
Exclusion
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 7 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05389852
Start Date
January 1 2023
End Date
February 7 2024
Last Update
February 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital du Valais
Sion, Switzerland, 1950